Annual review of immunology, vol. 26, 2008 by Paul, William E. & Littman, Dan R.




ANNUAL REVIEW OF IMMUNOLOGY, vol. 26, 2008; edited by William E. PAUL & Dan R. LITTMAN. Palo Alto, Annual Reviews, 2008. 794 
p. illust. ISBN: 978-0-8243-3026-2 
Two chapters in this volume deal with Immunology of Infectious 
Diseases. Circulating monocytes are increasingly implicated as essential 
players in defense against a range of microbial pathogens by supplying 
tissues with macrophage and dendritic cells precursors. In humans 
and mice, monocytes either specifically traffic into inflamed tissues 
or, in the absence of overt inflammation, constitutively maintain tissue 
macrophage/ dendritic cells populations. Inflammatory monocytes 
respond rapidly to microbial stimuli by secreting cytokines and 
antimicrobial factors, express the CCR2 chemokine receptor, and traffic 
to sites of microbial infection in response to monocyte chemoattractant 
protein (MCP)-1 (CCL2) secretion. In a very interesting issue, the in vivo 
mechanisms that promote chemokine secretion, monocyte differentiation 
and trafficking, and finally monocyte-mediated microbial killing remain 
active are focused by N.V. SERBINA et al. 
Generally, two major genetic approaches in the mouse have been 
used to identify host proteins and biochemical pathways that affect 
host response to many pathogens. The forward genetics, the more 
recent strategy, is an experimental approach in which gene mapping 
and positional cloning are used to elucidate the molecular mechanisms 
underlying phenotypic differences between two individuals for a given 
trait. This approach has been highly successful for the study of inbred 
mouse strains that show differences in innate susceptibility to several 
microbes and has revealed genes, proteins, and signaling pathways that 
play critical roles in the immune response to a large number of infectious 
agents. In a very interesting chapter, S.M. VIDAL et al. describe some 
of the most informative examples of such discoveries, with an emphasis 
on the implications of the discovered genes and proteins for our evolving 
understanding of innate or acquired immune defenses.
The area of Lymphocyte Development and Differentiation has 
been the target for several publications in previous volumes of this 
scientific series and much information has been obtained on this field. In 
2008, this important area is covered in seven chapters. Primary immune 
responses are initiated in secondary lymphoid organs that develop during 
embryogenesis or in the first few weeks after birth and are situated 
throughout the body at strategic sites where antigens from pathogens 
are most likely to be encountered. Its development occurs according to 
a highly coordinated series of interactions orchestrated by homeostatic 
chemokines, cytokines, and growth factors that attract hematopoietic 
cells to sites of future lymphoid organ development and promote their 
survival and differentiation. T.D. RANDALL et al. describe the current 
paradigm of secondary lymphoid organ development and discuss the 
differences in the timing, molecular interactions, and cell types involved 
in the development of each secondary lymphoid organ.
It is broadly recognized that thymus structure is key to the intrathymic 
selection of a selftolerant and self-MHC-restricted T cell antigen receptor 
(TCR) repertoire. A look at the evolution of the immune system strongly 
suggests that medulla-cortex organization is functionally important 
because, as soon as there was a thymus, this architectural hallmark of the 
thymus was present. In a very didactic way, H. RODEWALD focuses 
on significant recent advances in the field of thymus organogenesis, 
starting with a brief primer on the embryological origin of the thymus in 
phylogeny and concluding with the recently identified functional second 
thymus in mice, located in the neck.
Introduced to the field of immunology in 2002, two-photon 
microscopy has proved to be the method of choice for visualizing living 
cells deep within native tissue environments, and it is now revealing an 
elegant cellular choreograph of cell motility, antigen capture, and cell-cell 
interactions in a variety of in vivo settings. In a very interesting review, 
M.D. CAHALAN & I. PARKER first discuss the technology of two-
photon microscopy as applied to immunoimaging and then focus on its 
applications to live-cell imaging of immune cells in the lymph node under 
basal conditions and in response to antigenic challenge. 
The impaired growth of retroviruses, including HIV-1, in foreign and 
sometimes even in their natural hosts often stems from the action of potent 
host-encoded “viral restriction factors” that form important protective 
components of the innate immune system. The discovery of APOBEC3G 
and related cytidine deaminases as one class of host restriction factors 
and of the action of HIV-1 Vif as a specific APOBEC3G antagonist have 
stimulated scientific interest. The antiviral mechanisms of the APOBEC3 
family are not clear but appear to involve their intrinsic RNA binding 
and deaminase activities. Ya-Lin CHIU & W.C. GREENE summarize 
current understanding of the mechanism of action of the APOBEC3 
family of enzymes, the impact of these enzymes on viral evolution and 
disease progression, and their roles in controlling the replication of 
exogenous retroviruses. 
In the B cell lineage, Blimp-1 (B lymphocyte–induced maturation 
protein-1) is required for development of immunoglobulin-secreting 
cells and for maintenance of long-lived plasma cells (LLPCs). Blimp-1, 
discovered 16 years ago as a transcriptional repressor of the IFNβ 
promoter, is reviewed by G. MARTINS & K. CALAMEIN in a very 
up-to-date issue. 
Prior to antigen exposure, mice and humans constantly recreate a 
highly diverse repertoire of antigen-binding sites in pro- and pre-B cells in 
the bone marrow through the rearrangement of germ line immunoglobulin 
(Ig) variable (V), diversity (D), and joining (J) elements to form the 
heavy (H) and light (L) chain V regions in the Ig genes. Once an antigen 
appears, however, cognate mature B cells are stimulated to proliferate, 
differentiate, and migrate to germinal centers in secondary lymphoid 
organs, where they begin to express large amounts of activation-induced 
cytidine deaminase (AID), which initiates somatic hypermutation (SHM) 
of the antibody V regions that encode the antigen-binding sites. J.U. 
PELED et al. discuss SHM of the V region genes in mice and humans 
focusing on how the different enzymatic systems that are involved in SHM 
are organized and regulated. The authors first describe general features 
of SHM, followed by each of the mutation and repair systems involved 
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in V region hypermutation, and then they address the issue of the overall 
regulation of SHM. Finally, in a separate and very up-to-date chapter, J. 
STAVNEZER et al. discuss in detail the mechanism and regulation of 
class switch recombination.
In 2008, the important area of Cytokines is covered in three 
chapters. In the past two decades, major progress has been made in 
understanding the critical role of the interferon regulatory factor (IRF) 
family of transcription factors (IRFs) in the control of cell growth, cell 
survival, and oncogenesis. Since the first review in this Annual Review 
of Immunology series (2001), the crucial involvement of many IRFs in 
innate immune responses elicited by pattern recognition receptors (PRRs) 
has been clarified in greater detail. In his second review about this issue, 
T. TANIGUCHI focuses on current literature on how IRFs orchestrate 
and control homeostatic mechanisms of host defense. In addition to its 
contributions to immunity, the role of several IRFs in the regulation 
of the cell cycle and apoptosis and its implications for understanding 
susceptibility to and progression of several cancers is also discussed.
Early data support a central role for interleukin (IL)-2 in protective 
immune responses. It was quite surprising, therefore, that after the genes 
for IL-2 or two subunits of the IL-2R, IL-2Rα (CD25) and IL-2Rβ 
(CD122), were individually inactivated in mice by gene targeting, the 
resulting phenotype is not immunodeficiency, as predicted, but rather a 
very serious lymphoproliferative and autoimmune disorder. There is now 
much evidence that a defect in CD4+CD25+ Foxp3+ T regulatory (Treg) 
cell production is the main reason for lethal autoimmunity associated 
with IL-2/IL-2R deficiency. This cell population suppresses potentially 
autoreactive peripheral T cells that escape thymic negative selection. 
Emerging findings, however, suggest an essential role for IL-2 in immune 
memory. In a very exciting chapter, T.R. MALEK first introduces the 
basics of the IL-2/IL-2R system. After, current understanding of the 
dual role of IL-2 in maintaining tolerance and contributing to immunity 
in vivo with emphasis on T regulatory cell production and homeostasis 
is reviewed.
Interleukin-21 (IL-21), a potent immunomodulatory type I cytokine, 
was first observed to be produced by CD4+ Tcells and to modulate the 
proliferation and effector function of other lymphoid cells. Subsequently, 
however, IL-21 was observed to act on multiple nonlymphoid lineages as 
well and to be produced by innate immune natural killer T (NKT) cells 
and the more recently identified Th17 lineage. In an excellent issue, R. 
SPOLSKI & W.J. LEONARD review IL-21 biology and focus on its 
strong antitumor action via its effects on both NK and CD8+ T cells and 
also on its implications for cancer and autoimmunity. 
Much information has been obtained on the area of Autoimmunity. 
Rheumatoid Arthritis (RA) is often denoted an autoimmune disease, 
largely based on the presence of rheumatoid factors (RF). However, the 
presence of RF is not specific for RA and no experimental studies have 
demonstrated any proarthritogenic effects of RF. However, other data 
favor a possible role for autoimmune reactions in the disease. Over the 
past 10 years, there has been a major development in the field of immunity 
focused on antibodies to citrullinated proteins (ACPA), i.e., to peptides 
posttranslationally modified by the conversion of peptidylarginine 
to peptidylcitrulline. These antibodies are highly specific serological 
markers for RA, i.e., they exist in around 2% of normal populations, 
are also quite rare in other inflammatory conditions, and can be found 
in approximately 60% of RA patients. Recent studies on anticitrulline 
immunity, summarized by L. KLARESKOG et al., demonstrate that 
RA should be subdivided into at least two distinct subsets (ACPA-
positive and ACPA-negative disease) and that we might be able to devise 
immunotherapies specifically adapted to each arthritis subpopulations.
Although several autoimmune diseases are characterized by the 
presence of autoantibodies produced by autoreactive B cells, genetic 
and animal models point to a central role of autoreactive T cells as 
the primary mediators of autoimmune disease. Many genes identified 
as causing or predisposing to autoimmunity encode proteins that are 
involved in cell signal transduction. Protein tyrosine phosphatases 
(PTPs) are important regulators of many cellular functions and a growing 
number of PTPs have been implicated in human disease conditions, such 
as developmental defects, neoplastic disorders, immunodeficiency, and 
autoimmunity. T. VANG et al. first review the involvement of PTPs in 
human autoimmunity; next, they focus on the possible involvement 
of additional PTPs in susceptibility to autoimmune and inflammatory 
diseases. Finally, the possibility that PTPs regulating the immune system 
may serve as therapeutic targets is discussed.
Although mast cells have long been recognized as central players in 
allergy, recent evidence that these cells are activated by complement and 
can modulate both B and T cell responses suggests that mast cells can 
play also a central role in autoimmunity. In an excellent and challenging 
review, B.A. SAYED et al. first focus on key features of mast cells and 
describe the range of autoimmune diseases in which mast cells have 
been implicated. The defined and hypothesized mechanisms of mast 
cell action are then discussed, including the seemingly paradoxical 
antiinflammatory role of these cells in promoting tolerance. Finally, the 
genetically determined heterogeneity of mast cells and the implications 
for disease susceptibility are discussed in a very didactic way.
Two chapters are dedicated to Regulation of the immune response. 
One of the fundamental discoveries of modern immunology was the 
finding that antibody responses require “help” from Th2 cells which 
produce cytokines such as IL-4 and direct B cells to undergo Ig isotype 
switching to IgG and IgE. It is now apparent that a subset of nonpolarized 
CD4+ T cells termed follicular B helper T cells (TFH cells or T follicular 
helper cells) are the true helper cells for antibody responses, although 
other T cells such as Th2 cells, γδ T cells, and NKT cells may also 
contribute. TFH cells are distinguishable from Th1 and Th2 cells by 
several criteria, including chemokine receptor expression (CXCR5), 
location/migration (B cell follicles), and function (B cell help). Central 
to the function of CD4+ T cells is IL-21, a “helper” cytokine produced 
by TFH cells that potently stimulates the differentiation of B cells into 
antibody-forming cells through IL-21R. In an up-to-date issue, C. KING 
et al. first focus on some of the controversial questions concerning TFH 
cell differentiation, the relation of TFH cells to other T cell subsets such 
as Th2 and/or Th17, and the influence of several molecules that are highly 
expressed by TFH cells and most likely participate in T cell–dependent 
B cell differentiation. Finally, the authors argue that dysregulation of 
TFH cell function, and over- or underexpression of TFH cell-associated 
molecules such as ICOS or IL-21, most likely contributes to the 
pathogenesis of certain autoimmune diseases or immunodeficiencies.
Immune responses to foreign and self-antigens require specific and 
balanced responses to clear pathogens and tumors and yet maintain 
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tolerance. Induction and maintenance of T cell tolerance requires 
inhibitory signals delivered by programmed death 1 (PD-1) and its 
ligands, PD-L1 and PD-L2, on nonhematopoietic cells that can limit 
effector T cell responses and protect tissues from immune-mediated tissue 
damage. M.E. KEIR et al review recent advances in our understanding 
of the roles played by PD-1 and its ligands in regulating T cell activation 
and tolerance and consider the therapeutic potential of manipulation of 
PD-1 and its ligands.
Two important chapters are dedicated to the area of Inflammation. 
The two major clinical indications for intravenous IgG (IVIG) therapeutic 
application are IgG replacement therapy in primary and secondary 
immunodeficiencies and antiinflammation therapy in a variety of acute 
and chronic autoimmune diseases. Whereas the mechanism of IVIG 
activity in IgG replacement therapy may be explained by the presence 
of so-called natural or by the presence of common pathogen-specific IgG 
antiantibodies derived from previously immunized or vaccinated serum 
donors, the explanation of the anti-inflammatory activity in autoimmune 
diseases is unclear. In a very informative chapter, F. NIMMERJAHN & 
J.V. RAVETCH start with a description of the drug IVIG, summarize 
the clinical use of IVIG for different diseases and discuss recent data on 
the molecular mechanisms, with an emphasis on results obtained in in 
vivo model systems that might explain how this potent drug mediates 
its activity in vivo.
Although important for immunity, aberrant accumulation of T cells 
in the lung is seen in numerous noninfectious pulmonary inflammatory 
diseases such as asthma, where T lymphocytes in the lung are believed to 
orchestrate an abnormal inflammatory process. The hallmark of asthma 
is prominent chronic inflammation with accumulation of activated 
effector Tcells around the airways and in the airway lumen associated 
with reversible airway dysfunction. In a very interesting chapter, B.D. 
MEDOFF et al. summarize recent advances in mechanisms of T cell 
homing into the lung during asthma and present a paradigm for the 
mechanisms that control the movement of these cells into and out of 
the airways.
Recent data suggest that actin filaments play a dual role in T cell 
activation, enhancing cell activation by promoting conjugate formation 
and the assembly of signaling complexes, but also downregulating 
activation, perhaps by facilitating molecular movements that culminate 
in the internalization of the TCR regulatory proteins. The roles of actin 
filaments in T cell function and on the interplay between cytoskeletal 
changes and the signaling events associated with T cell activation are 
reviewed by J. BURKHARDT et al. 
The area of MHC is reviewed in two very up-to-date chapters. The 
rules for the conserved reaction of αβ T cell receptors (TCRs) with 
MHC proteins plus peptides are poorly understood, probably because 
thymocytes bearing TCRs with the strongest MHC reactivity are lost by 
negative selection. Thus, only TCRs with an attenuated ability to react 
with MHC appear on mature T cells. It is not clear until now if evolution 
had selected TCRs that reacted in some predictable way with MHC. P. 
MARRACK et al. describe relatively evolutionarily conserved amino 
acids in the TCR complementarity-determining regions (CDR) 1 and 
CDR2 that are often used to bind exposed areas of the MHCα-helices. 
The specialized capacities of dendritic cells (DCs) for acquiring, 
processing, retaining, and finally presenting peptides on major 
histocompatibility complex molecules are critical properties that account 
in part for their superior role in antigen presentation. Unlike other 
antigen-presenting cells, like macrophages, DCs are specialized for 
homing efficiently to the T cell zones of lymphoid organs for optimal 
interactions with T lymphocytes. Thus, the pathways and mechanisms 
that govern how DCs migrate to lymphoid and nonlymphoid tissues figure 
importantly in immune responses. G.J. RANDOLPH et al. compare the 
distinct migratory patterns of dendritic cell subsets and their precursors 
and discuss how the highly regulated patterns of DC migration in vivo 
may affect their roles in immunity. 
The field of Cytotoxic cells includes one excellent chapter by D. 
CHOWDHURY & J. LIEBERMAN. The granzymes (granule enzymes) 
are a family of highly homologous serine proteases contained in granules 
of cytotoxic T lymphocytes and natural killer cells that are released during 
granule exocytosis. Their major role is to induce cell death to eliminate 
viruses and tumor cells. The granzymes may also play a role in immune 
regulation by controlling the survival of activated lymphocytes and may 
also regulate inflammation by acting on extracellular substrates. The 
authors review what is known about the biochemistry, gene regulation, 
cell biology, functions, and inhibitors of the granzyme family and focus 
on recent studies that implicate granzymes in immune regulation and 
extracellular proteolytic functions in inflammation.
Finally, the prefatory chapter “Doing What I Like” by K. Frank 
AUSTEN summarizes his wonderful scientific journey and is obligatory 
to all readers.
The tradition of the series Annual Review of Immunology is to 
present the state of the art in different fields of Immunology. Like other 
volumes, this book offers a broad updated information on selected topics 
for students and researchers focusing recent progress on Basic and 
Clinical Immunology in a didactic manner of presentation.
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